Humacyte Inc at Oppenheimer Healthcare Conference (Virtual) Transcript
Good afternoon, everyone. Suraj Kalia, senior medical device analyst at Oppenheimer. Pleased to have Humacyte present this afternoon, the second day of the Oppenheimer Annual Healthcare Conference.
From Humacyte, we have CEO, Laura Niklason; and CFO, Dale Sander, with us. Folks, welcome. The floor is yours.
Thank you, Suraj. We're delighted to be here, and we really enjoy the Oppenheimer conferences that we've participated in.
So these are -- on this next slide here, these are the disclaimers that Humacyte has as a publicly traded company. Humacyte is traded on the NASDAQ under HUMA, or HUMA.
Humacyte is really a once-in-a-generation company. We are the only company on the planet that is making replacement human tissues essentially from scratch in our manufacturing suite. The tissues that we create are available off the shelf for patients who need them, and the way in which we grow these tissues is such that when they're
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
